$60,000 of PFIZER lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to drug development and pricing, generally vaccine safety and access, generally the 340B program, Issues related to pharmacy benefit managers, generally. H.R. 5509, the Safe Step Act Direct-to-Patient Prescription Drug Purchase Platforms Most Favored Nation drug pricing 340B HHS Pilot Program Model"
You can find more data on corporate lobbying on Quiver Quantitative.
PFE Congressional Stock Trading
Members of Congress have traded $PFE stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:
- SENATOR TOMMY TUBERVILLE sold up to $50,000 on 06/08.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/10 and 1 sale worth up to $15,000 on 03/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
PFE Insider Trading Activity
PFE insiders have traded $PFE stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PFE stock by insiders over the last 6 months:
- JENNIFER B. DAMICO (SVP & Controller) sold 2,000 shares for an estimated $51,400
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
PFE Hedge Fund Activity
We have seen 1,343 institutional investors add shares of PFE stock to their portfolio, and 1,213 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FISHER ASSET MANAGEMENT, LLC added 53,012,321 shares (+102.0%) to their portfolio in Q1 2026, for an estimated $1,480,104,002
- GOLDMAN SACHS GROUP INC added 7,058,154 shares (+17.6%) to their portfolio in Q1 2026, for an estimated $197,063,659
- ACADIAN ASSET MANAGEMENT LLC added 6,629,451 shares (+374.1%) to their portfolio in Q1 2026, for an estimated $185,094,271
- BNP PARIBAS FINANCIAL MARKETS removed 6,624,160 shares (-40.1%) from their portfolio in Q1 2026, for an estimated $184,946,547
- AMUNDI removed 6,237,910 shares (-13.3%) from their portfolio in Q1 2026, for an estimated $174,162,447
- ASSENAGON ASSET MANAGEMENT S.A. added 5,829,204 shares (+96.0%) to their portfolio in Q2 2026, for an estimated $140,367,232
- BANK OF NEW YORK MELLON CORP added 5,364,929 shares (+11.1%) to their portfolio in Q1 2026, for an estimated $149,788,817
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
PFE Price Targets
Multiple analysts have issued price targets for $PFE recently. We have seen 12 analysts offer price targets for $PFE in the last 6 months, with a median target of $27.5.
Here are some recent targets:
- Chris Schott from JP Morgan set a target price of $28.0 on 07/08/2026
- Rajesh Kumar from HSBC set a target price of $28.0 on 07/06/2026
- Carter Gould from Cantor Fitzgerald set a target price of $27.0 on 07/06/2026
- Trung Huynh from RBC Capital set a target price of $25.0 on 06/10/2026
- Geoff Meacham from Citigroup set a target price of $27.0 on 04/29/2026
- Jin Zhang from CICC set a target price of $33.0 on 04/16/2026
- Michael Yee from UBS set a target price of $27.0 on 04/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
